Related Experiment Video
Updated: Jul 17, 2026
03:20
Studying Chronic Exposure of Mice to Ultraviolet B Radiation
Published on: August 19, 2025
High-potency steroid use in children with vitiligo: a retrospective study
Jennifer Kwinter1, Janice Pelletier, Amina Khambalia
1Faculty of Medicine, University of Ottawa, Canada.
Journal of the American Academy of Dermatology
|January 17, 2007
Summary
Topical corticosteroids effectively treat childhood vitiligo, with 64% showing repigmentation. However, monitoring for systemic absorption and side effects like adrenal suppression is crucial, especially with head/neck involvement.
Area of Science:
- Pediatric Dermatology
- Dermatology
- Endocrinology
Background:
- Limited data exists on vitiligo treatments in children.
- Efficacy and safety of topical corticosteroids in pediatric vitiligo require further investigation.
Purpose of the Study:
- To evaluate the clinical outcomes and safety of moderate- to high-potency topical corticosteroids in children with vitiligo.
- To assess repigmentation rates and identify potential side effects, including systemic absorption.
Main Methods:
- Retrospective analysis of clinical data from 101 children (0-18 years) with vitiligo.
- Evaluation of lesion repigmentation, local steroid side effects, and laboratory markers (cortisol, thyrotropin levels).
Main Results:
- 64% of patients achieved lesion repigmentation.
- Local steroid side effects were observed in 26% of patients.
- Systemic absorption indicated by abnormal cortisol levels in 29% of patients, with higher risk in those with head/neck lesions.
Conclusions:
- Moderate- to high-potency topical corticosteroids demonstrate efficacy in treating pediatric vitiligo.
- Systemic absorption and potential side effects, such as adrenal suppression, are associated with these treatments.
- Close monitoring for side effects is recommended in children undergoing topical corticosteroid therapy for vitiligo.
Related Concept Videos
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
01:14Changes in Skin Color: Clinical Perspectives
The first thing a clinician sees is the skin, so the examination of the skin should be part of any thorough physical examination. Most skin disorders are relatively benign, but a few, including melanomas, can be fatal if untreated. A couple of the more noticeable disorders, albinism and vitiligo, affect the appearance of the skin and its accessory organs.
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
01:27Acne Infection
Acne is a multifactorial skin condition primarily affecting adolescents and young adults, with a global prevalence estimated to exceed 75% in this demographic. The condition is characterized by the formation of comedones (blackheads and whiteheads), papules, pustules, nodules, and, in severe cases, cysts, particularly in areas rich in sebaceous glands such as the face, neck, chest, and back. The pathogenesis involves increased sebum production, follicular hyperkeratinization, colonization by...
01:29Drug Dosing: Infants and Children
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...